Aktie A404YT ENTHEON BIOMEDICAL CORP.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Entheon Biomedical Corp.

Aktien

A404YT

CA29383X2023

ENBI

Verzögert Canadian Securities Exchange
Andere Börsenplätze
 18:48:03 19.04.2024 		% 5 Tage % 1. Jan.
0.16 CAD +3.23% Intraday Chart für Entheon Biomedical Corp. +23.08% +60.00%
26.03. Entheon Biomedical Corp. meldet Ergebnis für das Geschäftsjahr bis zum 30. November 2023 CI
2023 Entheon Biomedical Corp. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 31. August 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Entheon Biomedical Corp. announced that it has received CAD 0.1475 million in funding
Entheon Biomedical Corp. announced that it expects to receive CAD 0.1475 million in funding
Entheon Biomedical Corp. Reports Earnings Results for the Full Year Ended November 30, 2023
Entheon Biomedical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2023
Entheon Biomedical Corp. Announces Termination of Andrew Hegle as Chief Science Officer
Entheon Biomedical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2023
Heading Health Inc. announced that it has received $4.5 million in funding from a group of investors
Entheon Biomedical Corp. Reports Earnings Results for the First Quarter Ended February 28, 2023
Entheon Biomedical Corp. Announces Termination of Consulting Agreement with Cybin
Entheon Biomedical Corp. Auditor Raises 'Going Concern' Doubt
Entheon Biomedical Corp. Announces Resignation of Ruth Chun as Director
Entheon Biomedical Corp. Announces CFO Changes
Entheon Biomedical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2022
Entheon Biomedical Corp. Closes Patient Enrolment in its Clinical Research Study EBIQ-101
Entheon Biomedical : CFO Certification
Entheon Biomedical : CEO Certification
Entheon Biomedical : Quarterly Report
Entheon Biomedical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2022
Entheon Biomedical Corp. cancelled the transaction announced on April 5, 2022
Entheon Biomedical Corp. Reports Earnings Results for the First Quarter Ended February 28, 2022
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A404YT Aktie
  4. Nachrichten Entheon Biomedical Corp.
  5. Andere Sprachen